// App-Quantinova.ai

: Late Breaking Abstract - Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial

Researchers

Presenter

  • Tricia Mckeever

Principal Investigators

  • Kevin Mortimer

  • Lelia Duley

  • Lucy Bradshaw

  • Richard Swinden

  • Andrew Skeggs

  • Ian Pavord

  • Bernard Higgins

  • Samantha Walker

  • Mike Thomas

  • Graham Devereux

  • Andrew Wilson

  • Christopher Brightling

  • David Price

  • Janet Oborne

  • Eleanor Mitchell

  • Tim Harrison

  • Rebecca Haydock

Medical Centers

  • University of Nottingham, Nottingham, United Kingdom

  • Liverpool School of Tropical Medicine, Liverpool, UK

  • NIHR CRN: East Midlands, Nottingham, United Kingdom

  • University of Oxford, Oxford, United Kingdom

  • Newcastle upon Tyne Hospitals Trust, Newcastle upon Tyne, United Kingdom

  • Asthma UK, London, United Kingdom

  • University of Southampton, Southampten, United Kingdom

  • University of Aberdeen, Aberdeen, Scotland, United Kingdom

  • University of Leeds, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multicenteric

  • Parallel Group

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved